glp 1 agonist new drug List of approved and pending GLP-1 medications Beyond GLP-1: New 5-In-1 Compound
Description
The molecular formula is C187H291N45O59 and the molecular weight is 4113.58 g/mol
End-Users 16.5
Phase 2: active escalation (weeks 8 to 24) As doses increase toward the therapeutic range of 8 to 12 mg, heart rate effects become more apparent
Other Ingredients Vegetable cellulose capsules, chicory root inulin, microcrystalline cellulose
The most common ones include: Nausea Vomiting Diarrhea or constipation Stomach pain Fatigue Most side effects are mild and improve over time
